在接受间歇性血液透析 (2017-2024) 的尿素性狗中血液学,生物化学和酸变化
Diego Ribeiro1, Reiner S de Moraes1, Silvano S Geraldes1
1Department of Veterinary Clinic, Faculty of Veterinary Medicine and Zootechny, São Paulo State University (UNESP), Botucatu, São Paulo, Brazil.
Veterinary medicine and science
|March 5, 2026
概括
这项研究分析了接受间歇性血液透析 (IHD) 的功能衰竭犬的实验室变化. IHD有效地纠正了酸失衡,并消除了毒素,但贫血和低白蛋白需要持续监测.
科学领域:
- 兽医医学 兽医医学 兽医医学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 关键的护理关键的护理
背景情况:
- 实验室变量对于经过血液透析的患有脏疾病的动物的管理至关重要.
- 狗的尿血危机呈现出复杂的实验室异常,需要治疗干预.
研究的目的:
- 在间歇性血液透析 (IHD) 期间调查和描述慢性病 (CKD) 或急性损伤 (AKI) 的狗的实验室变量.
- 评估IHD对关键血液学和生物化学参数的影响.
- 提供数据,以优化治疗策略,并预测经过IHD的狗的结果.
主要方法:
- 追溯审查2017年至2024年期间接受IHD的CKD或AKI的狗的医疗记录.
- 对58只狗进行的149次IHD会议的分析,重点关注会议前和之后的实验室值.
- 统计分析以确定各种参数的显著变化.
主要成果:
- 在入院时患有贫血和低albuminemia的高患病率,随着IHD会议的增加而恶化.
- IHD有效地纠正了酸性血,代谢性酸症,并降低了肌素,尿素和水平.
- 在IHD后观察到红细胞,血红素和血小板的显著下降,以及pH,碳酸盐和电离的增加.
- 血克里特平均下降3.42-5%的每次会议被注意到.
结论:
- 间歇性血液透析在纠正酸干扰和消除狗的尿素毒素方面是有效的.
- 渐进性贫血和低albuminemia需要持续监测和积极的管理策略.
- 了解每次会议的血红素变化有助于规划流体选择和血液产品替代.
相关概念视频
01:25Hemodialysis III: Nursing Management
1.2K
The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
1.2K
01:24Hemodialysis II: Procedure and Complications
1.3K
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
1.3K
01:20Acute Kidney Injury V: Interprofessional Care
434
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
434
01:25Hemodialysis I: Introduction
2.5K
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
2.5K
01:25Peritoneal Dialysis III: Nursing Management
1.1K
Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
1.1K
01:25Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
287
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
287